Vimarsana
Biggest News Aggregation in the World

Srikanth Krishnamurthy News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Srikanth Krishnamurthy. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Srikanth Krishnamurthy Today - Breaking & Trending Today

First Nasal Spray For Treating Adult Covid Patients Launched In India - Vimarsana News

First Nasal Spray For Treating Adult Covid Patients Launched In India

Mumbai based innovation-driven global pharma company Glenmark has launched Nitric Oxide Nasal Spray (FabiSpray) in India, in partnership with SaNOtize, for treatment of adult patients suffering from COVID-19.

Source: ndtv.com
First nasal spray for treating adult COVID-19 patients launched in India - Vimarsana News

First nasal spray for treating adult COVID-19 patients launched in India

Glenmark received manufacturing and marketing approval from DCGI for Nitric Oxide Nasal Spray

Nasal Spray launched to treat adult Covid patients in India - Vimarsana News

Nasal Spray launched to treat adult Covid patients in India

Mumbai based pharma company Glenmark has launched the Nitric Oxide Nasal Spray under the brand name FabiSpray for the treatment of adult patients with Covid-19 infection. The nasal spray has been launched in partnership with Canadian ...

FabiSpray -- India's first nasal spray for treating adult COVID-19 patients launched - Vimarsana News

FabiSpray -- India's first nasal spray for treating adult COVID-19 patients launched

FabiSpray -- India's first nasal spray for treating adult COVID-19 patients launched

First nasal spray for treating adult COVID-19 patients launched in India - Vimarsana News

First nasal spray for treating adult COVID-19 patients launched in India

Mumbai based innovation-driven global pharma company Glenmark has launched Nitric Oxide Nasal Spray (FabiSpray) in India, in partnership with SaNOtize, for treatment of adult patients suffering from COVID-19.